Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents

MS Bader, M Loeb, D Leto, AA Brooks - Postgraduate medicine, 2020 - Taylor & Francis
Urinary tract infections (UTIs) caused by antibiotic-resistant Gram-negative bacteria are a
growing concern due to limited treatment options. Knowledge of the common uropathogens …

[HTML][HTML] Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients

B Gutiérrez-Gutiérrez, J Rodríguez-Baño - Clinical Microbiology and …, 2019 - Elsevier
Background Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) are a
frequent cause of invasive infections worldwide. Carbapenems are nowadays the most used …

[HTML][HTML] Frequency of drug-resistant bacterial isolates among pregnant women with UTI in maternity and children's hospital, Bisha, Saudi Arabia

GS Al-Shahrani, TM Belali - Scientific Reports, 2024 - nature.com
Urinary tract infections (UTIs) are one of the most prevalent bacterial infections affecting
humans, with a higher incidence among women. Pregnant women are at an increased risk …

[HTML][HTML] When and how to use MIC in clinical practice?

S Magréault, F Jauréguy, E Carbonnelle, JR Zahar - Antibiotics, 2022 - mdpi.com
Bacterial resistance to antibiotics continues to be a global public health problem. The choice
of the most effective antibiotic and the use of an adapted dose in the initial phase of the …

[HTML][HTML] Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae

F Barbier, S Bailly, C Schwebel, L Papazian… - Intensive Care …, 2018 - Springer
Purpose To investigate the clinical significance of infection-related ventilator-associated
complications (IVAC) and their impact on carbapenem consumption in mechanically …

[HTML][HTML] Piperacillin–tazobactam as alternative to carbapenems for ICU patients

B Pilmis, V Jullien, A Tabah, JR Zahar… - Annals of Intensive …, 2017 - Springer
Several studies suggest that alternatives to carbapenems, and particulary beta-lactam/beta-
lactamase inhibitor combinations, can be used for therapy of extended-spectrum beta …

[HTML][HTML] Pragmatic comparison of piperacillin/tazobactam versus carbapenems in treating patients with nosocomial pneumonia caused by extended-spectrum β …

L Zha, X Li, Z Ren, D Zhang, Y Zou, L Pan, S Li, S Chen… - Antibiotics, 2022 - mdpi.com
The effectiveness of piperacillin/tazobactam for managing nosocomial pneumonia caused
by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is unknown. To …

Controversies over the management of infections caused by Amp-C-and ESBL-producing Enterobacterales: what questions remain for future studies?

A Burillo, E Bouza - Current Opinion in Infectious Diseases, 2022 - journals.lww.com
Controversies over the management of infections caused by Am... : Current Opinion in
Infectious Diseases Controversies over the management of infections caused by Amp-C- and …

Epidemiology and risk factors for ureteral stent-associated urinary tract infections in non-transplanted renal patients: a systematic review of the literature

M Vallée, E Bey, K Bouiller, C Le Goux, R Pimpie… - World Journal of …, 2021 - Springer
Purpose Pathophysiology and risk factors for Ureteral Stent-Associated Urinary Tract
Infection (USAUTI) have been poorly investigated. This situation results in highly diverse …

Technologies for measuring pharmacokinetic profiles

AA Heller, SY Lockwood, TM Janes… - Annual Review of …, 2018 - annualreviews.org
The creation of a pharmacokinetic (PK) curve, which follows the plasma concentration of an
administered drug as a function of time, is a critical aspect of the drug development process …